Cardiovascular prevention - Here's to risk assessment

被引：0
|
作者：
Sleath, Jonathan D.
机构：
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2007年 / 335卷 / 7620期
关键词：
D O I：
10.1136/bmj.39339.477581.3A
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：577 / 578
页数：2
相关论文
共 50 条
  • [31] Cardiovascular Risk Assessment Campaigns in Community Pharmacies: contributing to CVD prevention
    Paulino, Ema
    Paulino, Ines
    Guerreiro, Marilia
    Fortunato, Ana Leonor
    Remedios, Ana Filipa
    Rosa, Mariana
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (02) : 613 - 613
  • [32] Let's talk about risk - Risk communication in GP cardiovascular prevention
    Herrmann, M
    Welke, J
    Segebrecht, S
    Schwantes, U
    PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE, 2005, 55 (02) : 133 - 133
  • [33] Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: an overview of systematic reviews
    Krzysztof Studziński
    Tomasz Tomasik
    Janusz Krzysztoń
    Jacek Jóźwiak
    Adam Windak
    BMC Cardiovascular Disorders, 19
  • [34] Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: an overview of systematic reviews
    Studzinski, Krzysztof
    Tomasik, Tomasz
    Krzyszton, Janusz
    Jozwiak, Jacek
    Windak, Adam
    BMC CARDIOVASCULAR DISORDERS, 2019, 19 (1)
  • [35] Cardiovascular risk prevention in children
    Martino F.
    Italian Journal of Pediatrics, 40 (Suppl 1) : 1 - 1
  • [36] Dyslipidemia: prevention of cardiovascular risk
    Allouch, H
    PRESSE MEDICALE, 1999, 28 (16): : 849 - 851
  • [37] Cardiovascular prevention and risk factors
    Agewall, Stefan
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (01) : 1 - 2
  • [38] Cardiovascular risk and atherosclerosis prevention
    Frohlich, Jiri
    Al-Sarraf, Ahmad
    CARDIOVASCULAR PATHOLOGY, 2013, 22 (01) : 16 - 18
  • [39] Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention
    Leistner, David M.
    Klotsche, Jens
    Pieper, Lars
    Stalla, Guenter K.
    Lehnert, Hendrik
    Silber, Sigmund
    Maerz, Winfried
    Wittchen, Hans-Ulrich
    Zeiher, Andreas M.
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2012, 46 (02): : 293 - 302
  • [40] Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease
    Ferket, Bart S.
    Hunink, M. G. Myriam
    Khanji, Mohammed
    Agarwal, Isha
    Fleischmann, Kirsten E.
    Petersen, Steffen E.
    HEART, 2017, 103 (07) : 491 - 499
12345